Adverse Effects

Brain Cancer

HER2-Positive Breast Cancer

Triple-Negative Breast Cancer

Breast Cancer

Colorectal Cancer

Esophageal Cancer

Gastric Cancer

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancers

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head & Neck Cancer

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Hematologic Oncology

Vaccines

Infection

Leukemia

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Lung Cancer

Lymphoma

Neuroendocrine Tumors

Oncology

Pediatric Cancers

Radiation Oncology

Sarcoma

Screening

Skin Cancer & Melanoma

Surgery

Thyroid Cancer

News

Global Bulletin

All News

FDA Approval Alert

Women in Oncology

Media

Expert Interviews

Around the Practice

Between the Lines

Face Off

From All Angles

Meeting of the Minds

OncView

Podcasts

Training Academy

Treatment Algorithms with the Oncology Brothers

Videos

Conferences

Publications

All Journals

Editorial Board

For Authors

Year in Review

Events

Frontline Forum

Satellite Sessions

CME/CE

Resources

Awareness Month

Interactive Tools

Nurse Practitioners/Physician's Assistants

Partners

Career Center

Subscribe

CancerNetwork is home to the journal Oncology & provides insights on the screening, early detection, diagnosis, treatment and prevention of cancers.

About

Advertise

CureToday.com

OncLive.com

OncNursingNews.com

TargetedOnc.com

Editorial

Contact

Terms and Conditions

Privacy

Do Not Sell My Personal Information

CancerNetwork - Oncology News and Clinical Expertise

Facebook

LinkedIn

Youtube

Spotlight

Clinical

Genitourinary Cancer

Gynecologic Cancer

Hematology

Skin Cancer

1rem

View

Treatment Strategies in Patients with MDS, MPN and AML

James K McCloskey, MD, Jamie L Koprivnikar, MD, and Christina Cho, MD discuss diagnosis, risk stratification, treatment options, and recent updates from ongoing trials in myelodysplastic syndrome (MDS), myeloproliferative neoplasms (MPNs), acute myeloid leukemia (AML), as well as allogeneic transplants.

James K McCloskey, MD, Jamie L Koprivnikar, MD, and Christina Cho, MD discuss the diagnosis of myelodysplastic syndrome (MDS) and the importance of risk stratification in guiding treatment decisions.

MDS Diagnosis and Risk Stratification

An overview of the various treatment options available for patients with MDS, with an emphasis on the importance of tailoring treatment choices based on risk profiles.

Tailoring Treatment Approaches for Patients with MDS

Insights concerning unmet needs in MDS treatment, ongoing trials, and recent updates in the treatment landscape.

Advancing MDS Care: Novel Therapies and Recent Updates

An overview of myeloproliferative neoplasms (MPNs) followed by an exploration of available treatment options and addressing differences in approach based on MPN subtypes such as essential thrombocytopenia, polycythemia vera, and myelofibrosis.

Factors Influencing Treatment Selection in Patients with MPNs

A closer look at the current unmet needs in MPN treatment, ongoing trials, and recent updates such as the MOMENTUM and FREEDOM trials.

Innovations in MPN Therapy: Ongoing Trials and Latest Findings

Drs. Koprivnikar, McCloskey, and Cho delve into the diagnostic process in acute myeloid leukemia (AML), treatment approaches for AML, and factors influencing treatment selection.

Diagnosis, Biomarker Testing, and Optimizing Treatment Selection for Patients with AML

Subject-matter experts highlight unmet needs in AML treatment, investigational therapies, and emerging targets showcased in recent studies.

Breakthroughs in AML: Investigational Therapies and Emerging Targets

Discussion centered around the role of allogeneic transplants in the treatment of MDS, MPN, and AML, focusing on the transplant process, eligibility criteria, patient selection, and post-transplant monitoring.

Understanding the Role of Allogeneic Transplants in Patient Care

 features trusted experts who actively address the latest data, practice advice, products, and devices in cancer care. Expert, multidisciplinary oncology providers can engage with these educational offerings to learn about the science driving treatment options.

Diagnosis, Biomarker Testing, and Optimizing Treatment Selection for Patients with AML

EP: 1.MDS Diagnosis and Risk Stratification

EP: 2.Tailoring Treatment Approaches for Patients with MDS

EP: 3.Advancing MDS Care: Novel Therapies and Recent Updates

EP: 4.Factors Influencing Treatment Selection in Patients with MPNs

EP: 5.Innovations in MPN Therapy: Ongoing Trials and Latest Findings

EP: 6.Diagnosis, Biomarker Testing, and Optimizing Treatment Selection for Patients with AML

EP: 7.Breakthroughs in AML: Investigational Therapies and Emerging Targets

EP: 8.Understanding the Role of Allogeneic Transplants in Patient Care

Newsletter